Introduction GenOdyssee is a drug discovery firm that employs a distinctive and patent-protected method to identify high-quality protein products. The company discovers naturally occurring variations of proteins that exhibit greater efficacy and safety compared to existing market versions of the same therapeutic proteins. This approach is particularly effective in identifying next-generation protein products for already established blockbuster markets. GenOdyssee possesses a proprietary genomic DNA database that represents the human population and screens for genetic variations of therapeutic proteins with enhanced properties. This drug discovery approach is founded on the premise that natural evolution may have resulted in unexpected mutations within the current population, which could potentially improve the therapeutic efficacy of known human therapeutic proteins. |